Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
CRISPR-engineered T cells in patients with refractory cancer.
Science. 2020 Feb 28;367(6481):eaba7365. doi: 10.1126/science.aba7365. Epub 2020 Feb 6.
Science. 2020.
PMID: 32029687
Clinical Trial.
CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy.
Salas-Mckee J, Kong W, Gladney WL, Jadlowsky JK, Plesa G, Davis MM, Fraietta JA.
Salas-Mckee J, et al.
Hum Vaccin Immunother. 2019;15(5):1126-1132. doi: 10.1080/21645515.2019.1571893. Epub 2019 Apr 2.
Hum Vaccin Immunother. 2019.
PMID: 30735463
Free PMC article.
Item in Clipboard
iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity.
Nobles CL, Reddy S, Salas-McKee J, Liu X, June CH, Melenhorst JJ, Davis MM, Zhao Y, Bushman FD.
Nobles CL, et al. Among authors: salas mckee j.
Genome Biol. 2019 Jan 17;20(1):14. doi: 10.1186/s13059-019-1625-3.
Genome Biol. 2019.
PMID: 30654827
Free PMC article.
Item in Clipboard
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells.
Agarwal S, Aznar MA, Rech AJ, Good CR, Kuramitsu S, Da T, Gohil M, Chen L, Hong SA, Ravikumar P, Rennels AK, Salas-Mckee J, Kong W, Ruella M, Davis MM, Plesa G, Fraietta JA, Porter DL, Young RM, June CH.
Agarwal S, et al. Among authors: salas mckee j.
Immunity. 2023 Oct 10;56(10):2388-2407.e9. doi: 10.1016/j.immuni.2023.09.001. Epub 2023 Sep 29.
Immunity. 2023.
PMID: 37776850
Free article.
Item in Clipboard
Cite
Cite